Hycamtin 4 mg, Lyophilisat

7680538570195 CH-53857 L01XX17 07.16.1.

Active substances:

Hycamtin 4 mg, Lyophilisat
Hycamtin 4 mg, Lyophilisat
Hycamtin 4 mg, Lyophilisat
1 / 3
google

Details

Product number
5385701
CPT
-
Packaging group
5
Unit
Durchstechflasche(n)
Composition
Praeparatio sicca: topotecanum 4 mg ut topotecani hydrochloridum, acidum tartaricum, mannitolum, acidum hydrochloridum aut natrii hydroxidum, pro vitro corresp. natrium 1.68 mg.

Articles (1)

Hycamtin 4 mg, Lyophilisat
Lyophilisat
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/06/2026
Professional SmPC
Français
20/06/2026
Professional SmPC
Italien
20/06/2026

Detailed composition

Substance Quantity Type Category
topotecanum
4.0 MG Substance Wirkstoff (Principe actif)
topotecani hydrochloridum
- Substance WIZUS
acidum tartaricum
- Substance HNIDK
mannitolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
1.68 MG Substance HBESI

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
53857
Drug name
Hycamtin, Lyophilisat
Galenic form
PULPA
ATC Code
L01XX17
Authorization status
Z
Dispensation category
A
First authorization
16/10/1996
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Ovarialkarzinom, kleinzelliges Bronchialkarzinom, Zervixkarzinom

Packaging details

Description (FR)
HYCAMTIN subst sèche 4 mg flac 5 pce
Description (DE)
HYCAMTIN Trockensub 4 mg Durchstf 5 Stk
Market launch
16/10/1996
Market withdrawal
06/03/2026
Narcotic (BTM)
No

Other packaging sizes

HYCAMTIN subst sèche 4 mg flac
1 DUR
View
HYCAMTIN subst sèche 1 mg flac
1 DUR
View
Buy us a coffee Explore the data